Clinical trial
Investigating the Effects of Nabilone on Endocannabinoid Metabolism in the Human Brain
NCT05885685 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Effects of Nabilone on Endocannabinoid Metabolism in the Human Brain
- Lead sponsor
- Centre for Addiction and Mental Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2023
- Completion date
- December 5, 2025
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy